Scarica l'app Stockscreener
47.34
2.79%
-1.36
Dopo l'orario di chiusura:
47.34
Precedente Chiudi:
$48.70
Aprire:
$49.37
Volume 24 ore:
513.59K
Relative Volume:
0.90
Capitalizzazione di mercato:
$2.24B
Reddito:
$1.10B
Utile/perdita netta:
$186.50M
Rapporto P/E:
12.52
EPS:
3.7817
Flusso di cassa netto:
$267.19M
1 W Prestazione:
-9.93%
1M Prestazione:
-10.68%
6M Prestazione:
-27.61%
1 anno Prestazione:
-27.21%
Intervallo 1D:
$47.29
$49.51
Intervallo di 1 settimana:
$47.29
$52.58
Portata 52W:
$42.62
$71.07
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Nome
Prestige Consumer Healthcare Inc
Settore
Telefono
(914) 524-6800
Indirizzo
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
47.34 | 2.31B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Aggiornamento | Sidoti | Neutral → Buy |
| 2024-12-09 | Downgrade | Sidoti | Buy → Neutral |
| 2024-06-21 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2022-11-17 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-06-29 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-04-07 | Ripresa | Sidoti | Neutral |
| 2020-03-26 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-24 | Iniziato | Oppenheimer | Perform |
| 2020-03-19 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2019-01-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2017-05-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Reiterato | B. Riley & Co. | Buy |
| 2016-11-17 | Iniziato | Gabelli & Co | Buy |
| 2016-08-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2016-03-08 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Iniziato | Piper Jaffray | Overweight |
| 2015-11-30 | Downgrade | Jefferies | Hold → Underperform |
| 2014-04-28 | Reiterato | B. Riley & Co. | Buy |
| 2014-04-28 | Reiterato | Oppenheimer | Outperform |
| 2013-07-09 | Iniziato | B. Riley & Co. | Buy |
Mostra tutto
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
PBH: Portfolio expansion and brand integration drive growth, with Clear Eyes recovery a key focus - TradingView
Prestige Consumer Healthcare at Barclays conference: growth via niche brands - Investing.com India
How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com - Investing.com India
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - The Manila Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Assessing a Promising 29.74% Potential Upside - DirectorsTalk Interviews
Is This the Right Time to Add PBH Stock to Your Portfolio? - TradingView
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare stock holds steady as investors watch valuation and growth - AD HOC NEWS
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test - Financial Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring A 29% Upside Potential - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential - DirectorsTalk Interviews
Nearly 40,000 Bottles of Eye Drops Recalled Nationwide - Yahoo
40,000 eye drop bottles recalled over potential contamination - Oman Observer
Nearly 40,000 eye drop bottles are recalled over potential contamination - The Seattle Times
40,000 bottles of eye drops across the US recalled over issues with sterility of product - inkl
Clear Eyes Maximum Itchy Eye Relief Recall: FDA Announces 39,060 Bottles RecalledNews and Statistics - IndexBox
Nearly 40,000 eye drops recalled nationwide over possible contamination - Fox Business
Great Lakes Advisors LLC Takes $2.98 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination - Fox Business
Clear Eyes eye drops recalled over sterility concerns - qz.com
FDA announces nationwide recall of nearly 40,000 Clear Eyes eye-drop bottles over potential contamination - The Economic Times
Is Prestige Consumer Healthcare’s (PBH) Upgraded 2027 Outlook and Halted Buybacks Reframing Its Growth Story? - webull.com
Rice Hall James & Associates LLC Acquires Shares of 689,692 Prestige Consumer Healthcare Inc. $PBH - MarketBeat
FDA recalls over 39K bottles of CLEAR EYES Maximum Itchy Relief drops - Glance by Eyes On Eyecare
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Holds Near $51.38 as Range-Bound Trading PersistsVolume Dry Up - vinanet.vn
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Prestige Consumer Healthcare Announces Operations Leadership Transition - The Globe and Mail
Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations - TradingView
Prestige Consumer Healthcare Inc. Announces Retirement of Jeffrey Zerillo from Senior Vice President, Operations, Effective August 14, 2026 - marketscreener.com
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover? - Yahoo Finance
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build - Investing.com
Prestige Consumer Healthcare (NYSE:PBH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Understanding Momentum Shifts in (PBH) - Stock Traders Daily
PBH: Deals Increase Sales Base by More than 20% - Smartkarma
Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference - The Manila Times
Prestige Consumer Executives Set for Aug. 12 Fireside Chat - Stock Titan
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo! Finance Canada
Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein - The National Law Review
Prestige Consumer Healthcare In (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare Q1 Earnings Call Highlights - TradingView
Prestige Consumer Healthcare (NYSE:PBH) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Prestige Consumer Healthcare (PBH) Stock Faces Margin Questions Despite Record Cash Flow - webull.com
Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Shares Bought by First Trust Advisors LP - MarketBeat
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72 - Moomoo
Prestige Consumer Healthcare Inc Azioni (PBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):